期刊文献+

侵犯性胸腺瘤的多层螺旋诊断 被引量:2

下载PDF
导出
摘要 目的分析侵犯性胸腺瘤在多层螺旋CT(MSCT)上的表现,讨论其临床意义。方法回顾性分析18例经手术及病理证实胸腺瘤的MSCT表现。结果肿瘤全部位于前上纵隔内,以中心向两侧生长9例,偏左侧5例,偏右侧4例;形态不规则6例,边缘呈分叶征9例;肿瘤与心脏、大血管呈灌铸型接触者3例;肿瘤内部密度不均匀,合并有坏死、液化改变7例,伴有钙化2例;增强扫描的病例中,有轻中度不均匀强化7例,均匀强化2例;10例患者存在肺侵犯;胸膜侵犯7例均被MSCT诊断;8例患者合并有心包积液,甚至出现心包填塞症状;血管受侵犯者7例;3例患者表现为心膈角区及腹腔受侵。结论 MSCT能清晰胸腺瘤对显示胸膜、心包和肺等脏器的侵犯,从而对病变范围进行可靠评价,并进行分期,进而为治疗方案的选择提供循证医学的依据。
作者 钱秋平 王苇
出处 《临床和实验医学杂志》 2011年第4期279-281,共3页 Journal of Clinical and Experimental Medicine
  • 相关文献

参考文献10

  • 1曹丹庆 蔡祖龙.全身CT诊断学[M].北京:人民军医出版社,2004.272-276.
  • 2宋楠,姜格宁.胸腺瘤的分类进展[J].中国胸心血管外科临床杂志,2009,16(2):132-136. 被引量:8
  • 3Tomiyama N,Johkon T,Mihara N,et al.Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings[J].AJR,2002,179(1):881-886.
  • 4Jeong YJ,Lee KS,Kin J,et al.Does CT of the thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis[J].AJR,2002,183(2):283-289.
  • 5Travis WD,Brambilla E,Muller-Hermelink HK,et al.Pat hology and Genetics of Tumours of the Lung,Pleura,Thymus and Heart.In:World Healt h Organization Classification of Tumours[M].Lyon,IARC Press,2004:142-153.
  • 6Suster S,Moran CA.Thymoma,atypical thymoma,and thymic carcinoma.A novel conceptual approach to the classification of thymic epithelial neoplasms[J].Am J Clin Pat hol,1999,111(6):826-833.
  • 7Travis WD,Brambilla E,Muller-Hermelink HK,et al.Pathology and genetics of tumours of the lung,pleura,thymus and heart[M] //Kleihues P,Sobin LH.WHO classification of tumors.Lyon,France:IARC Press,2004:145-197.
  • 8Inoue A,Tomiyama N,Fujimoto K,et al.MR imaging of thymic epithelial tumors:correlation with World Health Organization classification[J].Radial Med,2006,24(3):171-181.
  • 9Sonobe S,Miyamoto H,Izumi H,et al.Clinical usefulness of the WHO histological classification of thymoma[J].Ann Thorac Cardiovasc Surg,2005,11(6):367-373.
  • 10赵建青,李培岭,陈永辉.胸腺瘤的CT诊断价值[J].临床医学,2006,26(4):46-47. 被引量:3

二级参考文献42

  • 1陈金城,罗良平.纵隔肿瘤的以及大血管接触面的初步观察[J].中华放射学杂志,1993,27(2):78-81. 被引量:9
  • 2Kornstein MJ. Controversies regarding the pathology of thymomas. PatholAnnu, 1992,27(Pt2):1-15.
  • 3Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorae Cardiovasc Surg, 2003,126 (4):1134-1140.
  • 4StrobeI P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol, 2004,22 (8) : 1501-1509.
  • 5Engels EA, Pfeiffer RM. Malignant thymoma in the United States:demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer,2003,105(4):546-551.
  • 6Wright CD. Management of thymomas. Oncol Hematology, 2008, 65(2):109-120.
  • 7Bernatz PE, Harrison EG, Clagett OT. Thymoma: clinicopathologic study. J Thorac Cardiovasc Surg, 1,961, 42:424-444.
  • 8Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. HumPathol, 1978, 9(5):495 515.
  • 9Marino M, Mailer Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Palhol Anat Histopathol, 1985, 407(2):119-149.
  • 10Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer, 1985, 55(5):1074-1086.

共引文献90

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部